Skip to Main Content

Paper Details

Utilisation of composite endpoint outcome to assess efficacy of tocilizumab for non-infectious uveitis in the STOP-Uveitis Study.
Br J Ophthalmol
4
2023
Author NameAffiliation
Quan Dong NguyenByers Eye Institute, Stanford University
  • 1 - 1

Datasets

Release 1.2